Outpatients | Age
Item
male or female outpatients ≥ 18 years of age
boolean
C0029921 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Essential Hypertension
Item
participants with essential hypertension:
boolean
C0085580 (UMLS CUI [1])
Study Subject Therapy naive
Item
naive participants must have a mean sitting systolic blood pressure (mssbp) ≥
boolean
C0681850 (UMLS CUI [1,1])
C0919936 (UMLS CUI [1,2])
Sitting systolic blood pressure mean Visit Number
Item
150 mmhg and < 180 mmhg at visit 1 and visit 2. (participants are considered
boolean
C1319893 (UMLS CUI [1,1])
C0444504 (UMLS CUI [1,2])
C1549755 (UMLS CUI [1,3])
Antihypertensive Agents Absent
Item
'naïve' if they have never been treated with any antihypertensive medication.)
boolean
C0003364 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Study Subject All | Sitting systolic blood pressure mean Visit Number
Item
all participants must have a mssbp ≥ 150 mmhg and < 180 mmhg at visit 2
boolean
C0681850 (UMLS CUI [1,1])
C0444868 (UMLS CUI [1,2])
C1319893 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
C1549755 (UMLS CUI [2,3])
Informed Consent
Item
written informed consent to participate in this study prior to any study procedures
boolean
C0021430 (UMLS CUI [1])
Hypertension, severe
Item
severe hypertension
boolean
C4013784 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnant or nursing (lactating) women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Premenopausal state Contraceptive methods Absent
Item
pre-menopausal women not taking accepted form of birth control
boolean
C0232969 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
Serum potassium measurement
Item
serum potassium ≥ 5.5 meq/l (mmol/l) at visit 1
boolean
C0302353 (UMLS CUI [1])
Cardiovascular conditions
Item
history of cardiovascular conditions
boolean
C2015790 (UMLS CUI [1])
DIABETES MELLITUS INSULIN DEPENDENT UNCONTROLLED | DIABETES MELLITUS NON INSULIN DEPENDENT UNCONTROLLED
Item
uncontrolled type 1 or type 2 diabetes mellitus
boolean
C0743113 (UMLS CUI [1])
C0743118 (UMLS CUI [2])
Hypersensitivity Renin inhibitor | Calcium-channel blocker allergy | Hypersensitivity Pharmaceutical Preparations Chemical Structure Similar
Item
hypersensitivity to renin inhibitors, calcium channel blockers, or to drugs with similar chemical structures
boolean
C0020517 (UMLS CUI [1,1])
C1960108 (UMLS CUI [1,2])
C0570913 (UMLS CUI [2])
C0020517 (UMLS CUI [3,1])
C0013227 (UMLS CUI [3,2])
C0220807 (UMLS CUI [3,3])
C2348205 (UMLS CUI [3,4])
Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply.
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])